When Should a Provider Consider Insulin Human Inhalation Powder?
Document Type
Article
Publication Date
5-1-2016
Description
Insulin human inhalation powder, a rapid-acting inhaled insulin, was approved by the FDA in June 2014 for patients with type 1 or type 2 diabetes. For patients reluctant to start insulin therapy because of fear of injections, insulin human inhalation powder may be an alternative. This article discusses appropriate dosing, use, and monitoring.
Citation Information
Mospan, Cortney M.; Leonard, Chelsea; and Alley, Kelli. 2016. When Should a Provider Consider Insulin Human Inhalation Powder?. Journal of the American Academy of Physician Assistants. Vol.29(5). 16-18. https://doi.org/10.1097/01.JAA.0000482307.71186.01 PMID: 27124226 ISSN: 1547-1896